MEDICAMENT INCLUDING ANTIBODY COMPOSITION SPECIFICALLY BOUND TO HUMAN CC CHEMOKINE RECEPTOR 4 (CCR4)

摘要

There is a demand for a medicament which includes a genetically recombinant antibody specifically bound to human CC chemokine receptor 4 (referred to as CCR4 hereinafter) and at least one type of medicinal agent, and also for a medicament for administering a genetically recombinant antibody for CCR4 combined with at least one type of medicinal agent. Provided are a medicament which includes a genetically recombinant antibody specifically bound to CCR4 and at least one type of medicinal agent, and a medicament for administering a genetically recombinant antibody for CCR4 combined with at least one type of medicinal agent.